Developing High-Quality Lentiviral Vectors to Enhance Reliable Delivery & Reduce Cost

• Examining lentiviral delivery platforms to understand current industry benchmarks and opportunities for innovation
• Optimizing vector design and production strategies to enhance durable CAR expression
• Evaluating scalability and manufacturing readiness of lentiviral vectors to support sustainable in vivo clinical and commercial deployment

Speakers:

Luke Russell

Executive VP

Vyriad